Similar articles for PMID: 28619735

Year	Number of Results
1956	1
1973	1
2000	1
2002	1
2003	4
2004	4
2005	5
2006	2
2007	1
2008	8
2009	11
2010	5
2011	8
2012	10
2013	11
2014	16
2015	15
2016	10
2017	9
2018	14
2019	25
2020	15
2021	16
2022	12
2023	1
2024	0

1

The Evolving Role of Succinate in Tumor Metabolism: An ¹⁸F-FDG-Based Study.

Garrigue P, Bodin-Hullin A, Balasse L, Fernandez S, Essamet W, Dignat-George F, Pacak K, Guillet B, Taïeb D. Garrigue P, et al. J Nucl Med. 2017 Nov;58(11):1749-1755. doi: 10.2967/jnumed.117.192674. Epub 2017 Jun 15. J Nucl Med. 2017. PMID: 28619735 Free PMC article.

2

The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.

Zhang G, Li J, Wang X, Ma Y, Yin X, Wang F, Zheng H, Duan X, Postel GC, Li XF. Zhang G, et al. J Nucl Med. 2015 Apr;56(4):607-12. doi: 10.2967/jnumed.114.148254. Epub 2015 Feb 26. J Nucl Med. 2015. PMID: 25722447 Free article.

3

Metabolic Subtyping of Pheochromocytoma and Paraganglioma by ¹⁸F-FDG Pharmacokinetics Using Dynamic PET/CT Scanning.

van Berkel A, Vriens D, Visser EP, Janssen MJR, Gotthardt M, Hermus ARMM, Geus-Oei LF, Timmers HJLM. van Berkel A, et al. J Nucl Med. 2019 Jun;60(6):745-751. doi: 10.2967/jnumed.118.216796. Epub 2018 Nov 9. J Nucl Med. 2019. PMID: 30413658 Free PMC article. Clinical Trial.

4

Regulation of 18F-FDG accumulation in colorectal cancer cells with mutated KRAS.

Iwamoto M, Kawada K, Nakamoto Y, Itatani Y, Inamoto S, Toda K, Kimura H, Sasazuki T, Shirasawa S, Okuyama H, Inoue M, Hasegawa S, Togashi K, Sakai Y. Iwamoto M, et al. J Nucl Med. 2014 Dec;55(12):2038-44. doi: 10.2967/jnumed.114.142927. Epub 2014 Nov 5. J Nucl Med. 2014. PMID: 25453050 Free article.

5

Synthesis and Bioevaluation of Novel [¹⁸F]FDG-Conjugated 2-Nitroimidazole Derivatives for Tumor Hypoxia Imaging.

Yang X, Wang F, Zhu H, Yang Z, Chu T. Yang X, et al. Mol Pharm. 2019 May 6;16(5):2118-2128. doi: 10.1021/acs.molpharmaceut.9b00075. Epub 2019 Apr 19. Mol Pharm. 2019. PMID: 30964298

6

18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?

Taïeb D, Sebag F, Barlier A, Tessonnier L, Palazzo FF, Morange I, Niccoli-Sire P, Fakhry N, De Micco C, Cammilleri S, Enjalbert A, Henry JF, Mundler O. Taïeb D, et al. J Nucl Med. 2009 May;50(5):711-7. doi: 10.2967/jnumed.108.060731. Epub 2009 Apr 16. J Nucl Med. 2009. PMID: 19372492 Free article.

7

PET Imaging of ¹⁸F-(2 S,4 R)4-Fluoroglutamine Accumulation in Breast Cancer: From Xenografts to Patients.

Liu F, Xu X, Zhu H, Zhang Y, Yang J, Zhang L, Li N, Zhu L, Kung HF, Yang Z. Liu F, et al. Mol Pharm. 2018 Aug 6;15(8):3448-3455. doi: 10.1021/acs.molpharmaceut.8b00430. Epub 2018 Jul 20. Mol Pharm. 2018. PMID: 29985631

8

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

9

The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.

Cheong SJ, Lee CM, Kim EM, Lim ST, Sohn MH, Jeong HJ. Cheong SJ, et al. Nucl Med Biol. 2015 Feb;42(2):85-91. doi: 10.1016/j.nucmedbio.2014.08.013. Epub 2014 Sep 6. Nucl Med Biol. 2015. PMID: 25441255

10

Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?

Mees G, Dierckx R, Vangestel C, Laukens D, Van Damme N, Van de Wiele C. Mees G, et al. Mol Imaging. 2013 Jan-Feb;12(1):49-58. Mol Imaging. 2013. PMID: 23348791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

182 results

Results by year